These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14563459)

  • 1. Musculoskeletal manifestations in cystic fibrosis.
    Botton E; Saraux A; Laselve H; Jousse S; Le Goff P
    Joint Bone Spine; 2003 Sep; 70(5):327-35. PubMed ID: 14563459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies.
    Carlsson M; Eriksson L; Erwander I; Wieslander J; Segelmark M
    Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S95-100. PubMed ID: 14740434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Musculoskeletal involvement in cystic fibrosis.
    Parasa RB; Maffulli N
    Bull Hosp Jt Dis; 1999; 58(1):37-44. PubMed ID: 10431633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis.
    Sedivá A; Bartůnková J; Kolárová I; Hrusák O; Vávrová V; Macek M; Lockwood CM; Dunn AC
    J Autoimmun; 1998 Apr; 11(2):185-90. PubMed ID: 9650098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The arthropathy of cystic fibrosis.
    Dixey J; Redington AN; Butler RC; Smith MJ; Batchelor JR; Woodrow DF; Hodson ME; Batten JC; Brewerton DA
    Ann Rheum Dis; 1988 Mar; 47(3):218-23. PubMed ID: 3355258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease.
    Mahadeva R; Dunn AC; Westerbeek RC; Sharples L; Whitehouse DB; Carroll NR; Ross-Russell RI; Webb AK; Bilton D; Lomas DA; Lockwood CM
    Clin Exp Immunol; 1999 Sep; 117(3):561-7. PubMed ID: 10469063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis.
    Zhao MH; Jayne DR; Ardiles LG; Culley F; Hodson ME; Lockwood CM
    QJM; 1996 Apr; 89(4):259-65. PubMed ID: 8733512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Musculoskeletal manifestations and rheumatic symptoms in patients with cystic fibrosis (CF) no observations of CF-specific arthropathy.
    Koch AK; Brömme S; Wollschläger B; Horneff G; Keyszer G
    J Rheumatol; 2008 Sep; 35(9):1882-91. PubMed ID: 18688909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The musculoskeletal manifestations of cystic fibrosis.
    Rush PJ; Shore A; Coblentz C; Wilmot D; Corey M; Levison H
    Semin Arthritis Rheum; 1986 Feb; 15(3):213-25. PubMed ID: 3515562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of circulating immune complexes in patients with cystic fibrosis and arthritis.
    Wulffraat NM; de Graeff-Meeder ER; Rijkers GT; van der Laag H; Kuis W
    J Pediatr; 1994 Sep; 125(3):374-8. PubMed ID: 8071744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against bactericidal/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin.
    Rotschild M; Elias N; Berkowitz D; Pollak S; Shinawi M; Beck R; Bentur L
    Clin Exp Med; 2005 Jul; 5(2):80-5. PubMed ID: 16096858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPI.
    Schultz H; Csernok E; Schuster A; Schmitz TS; Ernst M; Gross WL
    Pediatr Allergy Immunol; 2000 May; 11(2):64-70. PubMed ID: 10893006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study.
    Buntain HM; Greer RM; Schluter PJ; Wong JC; Batch JA; Potter JM; Lewindon PJ; Powell E; Wainwright CE; Bell SC
    Thorax; 2004 Feb; 59(2):149-55. PubMed ID: 14760157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis.
    Lachenal F; Nkana K; Nove-Josserand R; Fabien N; Durieu I
    Eur Respir J; 2009 Nov; 34(5):1079-85. PubMed ID: 19443536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role for neutrophil extracellular traps in cystic fibrosis autoimmunity.
    Skopelja S; Hamilton BJ; Jones JD; Yang ML; Mamula M; Ashare A; Gifford AH; Rigby WF
    JCI Insight; 2016 Oct; 1(17):e88912. PubMed ID: 27777975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients.
    Lindberg U; Carlsson M; Hellmark T; Segelmark M
    J Immunol Res; 2015; 2015():947934. PubMed ID: 26273683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal bone turnover in cystic fibrosis adults.
    Aris RM; Ontjes DA; Buell HE; Blackwood AD; Lark RK; Caminiti M; Brown SA; Renner JB; Chalermskulrat W; Lester GE
    Osteoporos Int; 2002; 13(2):151-7. PubMed ID: 11905525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls.
    Greer RM; Buntain HM; Potter JM; Wainwright CE; Wong JC; O'Rourke PK; Francis PW; Bell SC; Batch JA
    Osteoporos Int; 2003 Jun; 14(5):404-11. PubMed ID: 12730764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing of E. coli DH5alpha in vitro.
    Schultz H; Schinke S; Mosler K; Herlyn K; Schuster A; Gross WL
    Pediatr Pulmonol; 2004 Feb; 37(2):158-64. PubMed ID: 14730661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in serum and sputum from patients with cystic fibrosis.
    Schiøtz PO; Egeskjold EM; Høiby N; Permin H
    Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):319-24. PubMed ID: 117671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.